Company Filing History:
1 out of 4,455 
1 out of 101 
Years Active: 2015
Title: Benjamin Scott Greener: Innovator in Sulfonamide Derivatives
Introduction
Benjamin Scott Greener is a notable inventor based in Sandwich, GB. He is recognized for his contributions to the field of medicinal chemistry, particularly in the development of sulfonamide derivatives. His work has the potential to impact the treatment of various disorders, especially pain management.
Latest Patents
Greener holds a patent for N-sulfonylbenzamide compounds. This invention relates to sulfonamide derivatives and their applications in medicine. The patent details processes for their preparation and the intermediates used in these processes. More specifically, it focuses on new sulfonamide Nav1.7 inhibitors, which are potentially useful in treating a wide range of disorders, particularly pain.
Career Highlights
Throughout his career, Benjamin Scott Greener has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pfizer Corporation and Icagen, Inc. His experience in these organizations has contributed to his expertise in medicinal chemistry and drug development.
Collaborations
Greener has collaborated with several professionals in his field. Some of his notable coworkers include Brian Edward Marron and David Simon Millan. These collaborations have likely enriched his research and development efforts.
Conclusion
Benjamin Scott Greener is a significant figure in the realm of medicinal chemistry, with a focus on sulfonamide derivatives. His patent for N-sulfonylbenzamide compounds showcases his innovative contributions to pain management therapies. His work continues to influence the pharmaceutical industry and improve treatment options for various disorders.